Temozolomide May Induce Therapy-Related Acute Lymphoblastic Leukaemia
Mizuki Ogura,Tomoki Todo,Minoru Tanaka,Yasuhito Nannya,Motoshi Ichikawa,Fumihiko Nakamura,Mineo Kurokawa
DOI: https://doi.org/10.1111/j.1365-2141.2011.08641.x
2011-01-01
British Journal of Haematology
Abstract:Abrahamsen, A.F., Borge, L. & Holte, H. (1990) Infection after splenectomy for Hodgkin’s disease. Acta Oncologica, 29, 167–170. Aleman, B.M., van den Belt-Dusebout, A.W., De Bruin, M.L., van ‘t Veer, M.B., Baaijens, M.H., de Boer, J.P., Hart, A.A., Klokman, W.J., Kuenen, M.A., Ouwens, G.M., Bartelink, H. & van Leeuwen, F.E. (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood, 109, 1878–1886. Andersson, A., Naslund, U., Tavelin, B., Enblad, G., Gustavsson, A. & Malmer, B. (2009) Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors – retrospective cohort analyses and a concept for prospective intervention. International Journal of Cancer, 124, 1914– 1917. Keel, A., Bennett, B., Sarkar, T.K., Forman, K.M., Dawson, A.A. & Jones, P.F. (1983) Splenectomy and infection in Hodgkin’s disease. British Journal of Surgery, 70, 278–280. Landgren, O., Bjorkholm, M., Konradsen, H.B., Soderqvist, M., Nilsson, B., Gustavsson, A., Axdorph, U., Kalin, M. & Grimfors, G. (2004) A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin’s lymphoma. Journal of Internal Medicine, 255, 664–673. Lynch, A.M. & Kapila, R. (1996) Overwhelming postsplenectomy infection. Infectious Disease Clinics of North America, 10, 693–707. Mauch, P. & Somers, R. (1992) Controversies in the use of diagnostic staging laparotomy and splenectomy in the management of Hodgkin’s disease. Annals of Oncology, 3(Suppl. 4), 41–43. Merk, K., Bjorkholm, M., Tullgren, O., Mellstedt, H. & Holm, G. (1990) Immune deficiency in family members of patients with Hodgkin’s disease. Cancer, 66, 1938–1943. Swerdlow, A.J., Barber, J.A., Hudson, G.V., Cunningham, D., Gupta, R.K., Hancock, B.W., Horwich, A., Lister, T.A. & Linch, D.C. (2000) Risk of second malignancy after Hodgkin’s disease in a collaborative British cohort: the relation to age at treatment. Journal of Clinical Oncology, 18, 498–509. Waghorn, D.J. (2001) Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. Journal of Clinical Pathology, 54, 214–218.